Conventional Cancer Therapies Can Accelerate Malignant Potential of Cancer Cells by Activating Cancer-Associated Fibroblasts in Esophageal Cancer Models

SIMPLE SUMMARY: In esophageal cancer, the 5-year survival rate for patients who underwent esophagectomy with chemoradiotherapy is poor, with an estimated rate of 32.4%. One reason for this outcome is the low response rate to preoperative chemotherapy or radiotherapy. In this study, we revealed that...

Descripción completa

Detalles Bibliográficos
Autores principales: Komoto, Satoshi, Noma, Kazuhiro, Kato, Takuya, Kobayashi, Teruki, Nishiwaki, Noriyuki, Narusaka, Toru, Sato, Hiroaki, Katsura, Yuki, Kashima, Hajime, Kikuchi, Satoru, Ohara, Toshiaki, Tazawa, Hiroshi, Fujiwara, Toshiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252052/
https://www.ncbi.nlm.nih.gov/pubmed/37296933
http://dx.doi.org/10.3390/cancers15112971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252052/
https://www.ncbi.nlm.nih.gov/pubmed/37296933
http://dx.doi.org/10.3390/cancers15112971

Ejemplares similares